Bryant Summers | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Bryant Summers
The Ohio State University

Bryant Summers
Affiliation The Ohio State University
Country United States
Scopus ID 56339860000
Documents 12
Citations 89
h-index 5
Subject Area Medicine and Health Sciences
Event International PopularScientist Awards

Bryant Summers is a researcher affiliated with The Ohio State University whose supplied bibliometric profile places the work within Medicine and Health Sciences. The profile records 12 documents, 89 citations, and an h-index of 5. These indicators provide a quantitative description of the supplied publication record and can be considered alongside publication topics, scholarly contributions, and the relevance of individual research outputs. The recognition context is the International PopularScientist Awards.

Abstract

Bryant Summers is presented in the supplied recognition profile as a Medicine and Health Sciences researcher affiliated with The Ohio State University in the United States. The supplied Scopus identification number is 56339860000, with a reported publication record of 12 documents, 89 citations, and an h-index of 5. These bibliometric measures provide a concise quantitative view of the research record. The supplied publication information also identifies scholarship concerning kidney-function estimation and medication-related decision-making as part of the broader evidence base relevant to contemporary clinical pharmacy and health sciences research.

Keywords

  • Medicine and Health Sciences
  • Clinical Pharmacy
  • Kidney Function
  • Estimated Glomerular Filtration Rate
  • Medication-Related Decision-Making
  • Research Impact
  • Bibliometrics

Introduction

Research in medicine and health sciences frequently connects clinical evidence, pharmacotherapy, kidney function assessment, and methods for supporting treatment decisions. One supplied publication associated with this research context is the 2026 article titled “Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.” The article was published in the Journal of the American College of Clinical Pharmacy, volume 9, issue 2, as article e70153. [2]

Research Profile

The supplied researcher profile identifies Bryant Summers with The Ohio State University and places the research activity in Medicine and Health Sciences. The reported Scopus identifier is 56339860000. The supplied bibliometric figures are 12 documents, 89 citations, and an h-index of 5. Scopus author identifiers and bibliometric indicators are useful for distinguishing an author’s indexed publication record and summarizing citation activity, although such indicators represent only selected quantitative dimensions of scholarly work. [1]

Research Contributions

The supplied publication title identifies a research discussion focused on estimated glomerular filtration rate and medication-related decision-making. The associated article describes the transition toward race-free eGFR approaches and considers how contemporary kidney-function assessment can be incorporated into clinical pharmacy practice. [2] The topic is relevant to medication dosing, renal function assessment, clinical decision support, and the development of standardized healthcare practices.

Publications

The supplied publication material includes a 2026 article concerning race-free estimated glomerular filtration rate and medication-related decision-making. The article is identified in the journal record as a review and opinion contribution associated with the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. [2]

  • Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Journal of the American College of Clinical Pharmacy, 9(2), e70153.

Research Impact

The supplied bibliometric profile reports 89 citations across 12 documents and an h-index of 5. These figures indicate that the indexed publication record has accumulated measurable citation activity. [1] Bibliometric indicators should be interpreted in relation to field-specific publication practices, database coverage, authorship patterns, publication age, and the qualitative significance of individual contributions.

Award Suitability

The supplied profile contains several documented elements that can be considered in an academic recognition review, including an institutional affiliation, a Scopus author identifier, publication and citation metrics, and a defined subject area. The publication material supplied for this profile also demonstrates engagement with a contemporary clinical topic involving renal function estimation and medication-related decision-making.

Conclusion

Bryant Summers is presented in the supplied profile as a Medicine and Health Sciences researcher affiliated with The Ohio State University. The reported record comprises 12 documents, 89 citations, and an h-index of 5, with Scopus Author ID 56339860000. The supplied publication context concerns kidney-function estimation and medication-related decision-making, including contemporary discussion of race-free estimated glomerular filtration rate and its implementation in clinical pharmacy practice. [1] [2]

References

  1. Elsevier. (n.d.). Scopus author details: Bryant Summers, Author ID 56339860000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56339860000
  2. Wallace, J. L., Rungkitwattanakul, D., Khan, R. W., Anderson, L., Anderson, E. R., El Nekidy, W. S., Nemecek, B. D., Meaney, C. J., Prasad-Reddy, L., Salama, L., Hudson, J. Q., Kane-Gill, S. L., Barreto, E. F., Bzowyckyj, A. S., & St. Peter, W. (2026). Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Journal of the American College of Clinical Pharmacy, 9(2), e70153.
    https://doi.org/10.1002/jac5.70153
  3. Pierce, D., Brokhof, M. M., Fredrick, S. R., et al. (2026). Comment on “Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.” Journal of the American College of Clinical Pharmacy.
    https://doi.org/10.1002/jac5.70201
  4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4S), S117–S314.
    https://doi.org/10.1016/j.kint.2023.10.018
  5. St. Peter, W. L., Bzowyckyj, A. S., Anderson-Haag, T., et al. (2024). Moving Forward From Cockcroft-Gault Creatinine Clearance to Race-Free Estimated Glomerular Filtration Rate to Improve Medication-Related Decision-Making in Adults Across Healthcare Settings. American Journal of Health-System Pharmacy, 82, zxae317.
    https://doi.org/10.1093/ajhp/zxae317

Merve Ecem Albayrak | Medicine | Women Researcher Award

Published on by International Popular Scientist Awards

Women Researcher Award

Merve Ecem Albayrak
İstanbul Medicana Çamlıca Hastanesi

Merve Ecem Albayrak
Affiliation İstanbul Medicana Çamlıca Hastanesi
Country Turkey
Documents 2
Subject Area Medicine
Event International PopularScientist Awards
Orcid 0009-0006-3332-8530

Merve Ecem Albayrak is a medical researcher affiliated with İstanbul Medicana Çamlıca Hastanesi in Turkey. Her documented scholarly work includes research concerning women’s health, gynecological conditions, cervical disease, and the management of endometrioma during the perimenopausal and postmenopausal periods. The available publication record comprises two documents, including a 2025 book chapter and a 2023 population-based journal article. [1] [2]

Abstract

Merve Ecem Albayrak is associated with medical research focused on women’s health and gynecological medicine. Her documented publications address two clinically relevant areas: the management of endometrioma in perimenopausal and postmenopausal women, and the prevalence of human papillomavirus (HPV) together with risks associated with premalignant and malignant cervical lesions among women with asymptomatic cervical erosion. [1] [2] These works provide a research profile situated within contemporary clinical and population-based approaches to women’s reproductive health.

Keywords

Merve Ecem Albayrak; Medicine; women’s health; gynecology; endometrioma; perimenopause; postmenopause; cervical erosion; human papillomavirus; HPV; cervical lesions; population-based research.

Introduction

Women’s health research encompasses clinical conditions affecting reproductive organs, hormonal transitions, screening, infection, and the prevention or identification of disease. Within this broad field, endometrioma and cervical disease represent distinct but important areas of gynecological investigation. Albayrak’s documented publications address both subjects, linking clinical management with population-based investigation of cervical health. [1] [2]

The publication record includes a book chapter titled Perimenapozal ve Postmenapozal Dönemde Endometrioma Yönetimi, published in 2025, and a journal article examining HPV prevalence and the risk of premalignant and malignant lesions in women with asymptomatic cervical erosion, published in 2023. [1] [2]

Research Profile

Albayrak’s available scholarly record is situated primarily within medicine, with an emphasis on gynecological and women’s health topics. The documented works cover both clinical management and epidemiological assessment. The 2025 book chapter addresses endometrioma management specifically during perimenopausal and postmenopausal periods, while the 2023 study investigates HPV prevalence and cervical lesion risk in a population of women with asymptomatic cervical erosion. [1] [2]

Research Contributions

The documented research contributions can be described across two complementary areas:

  • The 2025 book chapter addresses the management of endometrioma in perimenopausal and postmenopausal women, focusing on a clinical topic relevant to gynecological care during later reproductive and post-reproductive life stages. [1]
  • The 2023 population-based study examines HPV prevalence and the risk of premalignant and malignant lesions among women with asymptomatic cervical erosion, contributing to research concerning cervical health and disease-risk assessment. [2]
  • Taken together, the publications demonstrate engagement with both clinical management and population-oriented investigation within women’s health and gynecological medicine.

Publications

The documented publications associated with Merve Ecem Albayrak are listed below. The publication information and DOI identifiers are based on the supplied Crossref records.

  1. Perimenapozal ve Postmenapozal Dönemde Endometrioma Yönetimi. Book chapter, 2025-01-21. Contributor: Merve Ecem Albayrak.
  2. HPV prevalence and risk of premalignant and malignant lesions in women with asymptomatic cervical erosion: A population-based study. Bolu Abant Izzet Baysal Universitesi Tip Fakultesi Abant Tip Dergisi, 2023-11-10. Contributors: Pelin OYARDI; Funda DAĞISTANLI; Merve Ecem ALBAYRAK; Mustafa Ayhan EKİCİ.

Research Impact

The available publications address clinically relevant questions in women’s health. The endometrioma chapter provides a focused discussion of management in perimenopausal and postmenopausal populations, while the population-based cervical-health study addresses HPV prevalence and the occurrence of premalignant and malignant lesions in women with asymptomatic cervical erosion. [1] [2]

Award Suitability

The Women Researcher Award associated with the International PopularScientist Awards provides a recognition context for researchers whose documented scholarly activities fall within relevant scientific and professional fields. Albayrak’s available record includes two publications in medicine addressing women’s health and gynecological topics, including endometrioma management and cervical disease-related research. [1] [2]

Any formal award determination should be based on the applicable criteria, documentation, evaluation procedures, and verified research record of the awarding organization. The information presented on this page describes the documented research profile and does not independently establish an award outcome. The official award website is available through the external links section. [4]

Conclusion

Merve Ecem Albayrak’s documented academic profile is centered on medicine, with publications addressing clinically relevant aspects of women’s health and gynecology. Her available record includes a book chapter on endometrioma management during perimenopausal and postmenopausal periods and a population-based study concerning HPV prevalence and cervical lesion risk. [1] [2] These publications provide the principal documented basis for describing her research profile in connection with the Women Researcher Award.

References

  1. Crossref. (2025). Perimenapozal ve Postmenapozal Dönemde Endometrioma Yönetimi. Book chapter.
    https://doi.org/10.37609/akya.3331.c11035
  2. Crossref. (2023). HPV prevalence and risk of premalignant and malignant lesions in women with asymptomatic cervical erosion: A population-based study. Bolu Abant Izzet Baysal Universitesi Tip Fakultesi Abant Tip Dergisi.
    https://doi.org/10.47493/abantmedj.1365241
  3. ORCID. (n.d.). ORCID record: Merve Ecem Albayrak.
    https://orcid.org/0009-0006-3332-8530
  4. International PopularScientist Awards. (n.d.). Official award website.
    https://popularscientist.com/

Jeffrey Velotta | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Dr. Jeffrey Velotta | Medicine | Best Researcher Award

Thoracic Surgeon | Kaiser Permanente Northern California | United States

Dr. Jeffrey Velotta, MD, FACS, is a highly accomplished thoracic surgeon and academic leader recognized for his contributions in lung cancer, mesothelioma, and thoracic surgical innovation. He serves as Associate Thoracic Surgeon at Kaiser Permanente Oakland Medical Center, where he directs the Northern California Mesothelioma Program. In parallel, he is Clinical Professor at Kaiser Permanente Bernard J. Tyson School of Medicine, Assistant Professor of Surgery at UCSF, and Global Faculty Member at Stanford University’s Center for Asian Health Research and Education. Dr. Velotta has earned recognition for his outstanding mentorship, teaching, and clinical care, while maintaining a strong presence in research addressing lung cancer disparities in Asian American populations. His leadership extends into numerous national committees, editorial boards, and professional societies, shaping policy and advancing education in thoracic surgery. His career integrates patient-centered care, surgical excellence, mentorship, and innovative research that collectively advance thoracic oncology and health equity.

Profile

Scopus

Orcid

Education

Dr. Jeffrey Velotta completed his undergraduate studies at the University of California, Santa Barbara, earning a Bachelor of Science degree in Physiology with honors. He pursued medical education at The George Washington University School of Medicine, graduating with distinction and election to the Alpha Omega Alpha Honor Society. His post-graduate surgical training included internship and residency in General Surgery at UCLA David Geffen School of Medicine, where he served as Chief Resident and received recognition for teaching excellence. He subsequently completed a postdoctoral research fellowship in Cardiothoracic Surgery at Stanford University School of Medicine under Dr. Robert C. Robbins. His advanced surgical training culminated with a residency and chief residency in Thoracic Surgery at Harvard Medical School’s Brigham and Women’s Hospital. This educational foundation, spanning leading institutions in California and Massachusetts, provided him with comprehensive expertise in general, cardiothoracic, and thoracic surgery, research methodology, and leadership in academic medicine.

Professional Experience

Dr. Jeffrey Velotta has established a distinguished career blending clinical practice, academic medicine, mentorship, and research. At Kaiser Permanente Oakland Medical Center, he serves as Associate Thoracic Surgeon and directs the Northern California Mesothelioma Program, leading multidisciplinary approaches for complex thoracic cancers. He is Clinical Professor at the Kaiser Permanente Bernard J. Tyson School of Medicine and Assistant Professor of Surgery at UCSF, where he actively teaches, mentors, and guides future surgeons. At Stanford University’s Center for Asian Health Research and Education, he contributes as Global Faculty, advancing population-based studies. His experience includes leadership roles in medical education, admissions committees, and national thoracic societies. He has mentored dozens of medical students, residents, fellows, and junior faculty, many of whom have progressed to prominent academic and clinical roles. His work spans surgery, mentorship, and health equity research, demonstrating his commitment to advancing thoracic oncology while training the next generation of physician leaders.

Awards and Honors

Dr. Jeffrey Velotta has received numerous awards recognizing excellence in surgery, mentorship, teaching, and research. His accolades include election as Fellow of the American College of Surgeons, induction into the American Association of Thoracic Surgeons, and honors from the Society of Asian Academic Surgeons. He has earned multiple UCSF Academy of Medical Educators awards for teaching and mentorship, as well as faculty teacher of the year recognition from UCSF-East Bay. Nationally, he has been awarded by the Society of Thoracic Surgeons, American College of Surgeons, and professional groups for leadership and contributions to clinical practice. His recognition extends to Castle Connolly Top Doctor designations, Reviewer of the Year awards for thoracic journals, and leadership development awards. Early in his career, he received young investigator and surgical excellence awards at Harvard and UCLA. These honors highlight his sustained contributions across clinical care, medical education, surgical innovation, and advancing health equity.

Research Focus

Dr. Jeffrey Velotta research focuses on lung cancer, mesothelioma, and thoracic surgical innovation, with a special emphasis on cancer disparities in Asian American populations. He has led multiple funded projects investigating lung cancer risk among Asian female non-smokers, equitable biomarker testing, outcomes of robotic and minimally invasive thoracic surgery, and strategies to improve access to lung cancer screening. His studies also explore guideline-concordant care, patient outcomes across diverse health systems, and innovative treatments such as cryoablation in mesothelioma surgery. At Stanford CARE, he advances Asian American health research, integrating clinical data with population-level insights. His collaborative work spans industry-funded trials, community health grants, and national cancer consortiums. As an editorial board member and peer reviewer for leading thoracic journals, he contributes to shaping academic discourse in his field. His research program embodies a blend of clinical practice, population health, and translational science aimed at reducing disparities and improving thoracic oncology care.

Publication

Chest Wall Reconstruction Using Biologic Mesh to Cover Soft Tissue Defects: A Narrative Review
Year: 2025

The Impact of Preoperative Invasive Nodal Staging on Unexpected Mediastinal Upstaging in Early-Stage Non-small Cell Lung Cancer
Year: 2025

Time to surgery in early-stage non–small cell lung cancer: Defining the optimal diagnosis-to-resection interval to reduce mortality
Year: 2025

Racial/Ethnic Disparities in Lung Cancer Surgery Outcomes in the USA
Year: 2025

Elevated risk of lung cancer among Asian American women who have never smoked: an emerging cancer disparity
Year: 2025

Conclusion

Dr. Jeffrey Velotta is highly suitable for recognition through this research award. His career embodies the integration of clinical excellence, impactful research, and dedicated mentorship. His contributions to advancing thoracic oncology, particularly in addressing disparities among Asian American populations, represent both innovation and social responsibility. With a strong track record of funded research, academic leadership, and peer recognition, he stands out as a leader whose work continues to shape the future of thoracic surgery and cancer care. His trajectory demonstrates both current excellence and potential for continued advancement, making him an exemplary candidate for this distinction.